Kelso Pharma, the Apposite Capital-backed specialty pharma, has secured over £140m of acquisition funding, a proportion of which was used by Kelso in its acquisition of Alturix in February. The…
Kelso Pharma, the Apposite Capital-backed specialty pharma, has secured over £140m of acquisition funding, a proportion of which was used by Kelso in its acquisition of Alturix in February. The…
…
…